ArticleBBA clinical2016

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD).

Paul L Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.